Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Follow-Up of Patients Exposed to Lentiviral-Based CAR T-Cell Therapy

NCT02445222 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT02445222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02445222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Follow-Up of Patients Exposed to Lentiviral-Based CAR T-Cell Therapy
Lead sponsor
Novartis Pharmaceuticals
Phase
Phase 3
Overall status
Recruiting
Start date
November 2, 2015
Completion date
April 18, 2039
Enrollment
1,105 (estimated)
Sites
120

Conditions

As the registry lists them; a condition with its own page is linked.

long term safety of patients receiving car-t in an eligible clinical trial or managed access program